Literature DB >> 24700155

Whites and blacks have similar risk of metachronous advanced colorectal neoplasia.

Joann Kwah1, Paul C Schroy, Brian C Jacobson, Audrey H Calderwood.   

Abstract

BACKGROUND: Current guidelines for surveillance of colonic neoplasia are based on data from predominantly white populations, yet whether these recommendations are applicable to blacks is unknown. AIM: To define the prevalence of advanced colorectal neoplasia (ACN) among whites and blacks undergoing surveillance colonoscopy.
METHODS: This was a retrospective, cross-sectional analysis of asymptomatic, average-risk non-Hispanic white (N = 246) and non-Hispanic black (N = 203) patients with colorectal neoplasia who underwent baseline screening colonoscopy between January 1, 2000, and December 31, 2007, and a surveillance colonoscopy before December 31, 2010, at an academic safety-net hospital. The main outcome measure was the prevalence of ACN, defined as a tubular adenoma or sessile serrated adenoma (SSA) ≥ 10 mm, any adenoma with villous histology or high-grade dysplasia, any serrated lesion with dysplasia, or invasive cancer at surveillance.
RESULTS: During a median follow-up of 4.3 years, the overall prevalence of ACN at surveillance was similar among blacks and whites (11.3 vs. 9.8 %; P = 0.59) with an odds ratio of 1.18 (95 % CI 0.65-2.16) [corrected]. Blacks and whites with non-advanced neoplasia had similar rates of ACN at the 1-3, 4-5, and >5 year follow-up intervals. Blacks with ACN or multiplicity at baseline had higher rates of ACN at the 1- to 3-year interval compared with whites, but the difference was non-significant (26.7 vs. 12.5 %; P = 0.32). No interval cancers were observed for either group.
CONCLUSIONS: The overall prevalence of ACN was similar between non-Hispanic blacks and non-Hispanic whites undergoing surveillance in a safety-net healthcare setting suggesting that current surveillance guidelines are appropriate for both blacks and whites.

Entities:  

Mesh:

Year:  2014        PMID: 24700155     DOI: 10.1007/s10620-014-3132-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

Review 1.  Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  David A Lieberman; Douglas K Rex; Sidney J Winawer; Francis M Giardiello; David A Johnson; Theodore R Levin
Journal:  Gastroenterology       Date:  2012-07-03       Impact factor: 22.682

2.  Determinants of compliance with colonoscopy in patients with adenomatous colon polyps in a veteran population.

Authors:  A A Siddiqui; A Patel; S Huerta
Journal:  Aliment Pharmacol Ther       Date:  2006-12       Impact factor: 8.171

3.  Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.

Authors:  T K Weber; H M Chin; M Rodriguez-Bigas; B Keitz; R Gilligan; L O'Malley; E Urf; N Diba; J Pazik; N J Petrelli
Journal:  JAMA       Date:  1999 Jun 23-30       Impact factor: 56.272

4.  Racial and ethnic trends of colorectal cancer screening among Medicare enrollees.

Authors:  Chyke A Doubeni; Adeyinka O Laiyemo; Carrie N Klabunde; Angela C Young; Terry S Field; Robert H Fletcher
Journal:  Am J Prev Med       Date:  2010-02       Impact factor: 5.043

5.  Adenoma characteristics as risk factors for recurrence of advanced adenomas.

Authors:  M E Martínez; R Sampliner; J R Marshall; A K Bhattacharyya; M E Reid; D S Alberts
Journal:  Gastroenterology       Date:  2001-04       Impact factor: 22.682

6.  Short- and long-term risk of colorectal adenoma recurrence among whites and blacks.

Authors:  Adeyinka O Laiyemo; Chyke Doubeni; Hassan Brim; Hassan Ashktorab; Robert E Schoen; Samir Gupta; Aline Charabaty; Elaine Lanza; Duane T Smoot; Elizabeth Platz; Amanda J Cross
Journal:  Gastrointest Endosc       Date:  2013-01-18       Impact factor: 9.427

7.  Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs.

Authors:  Douglas A Corley; Christopher D Jensen; Amy R Marks; Wei K Zhao; Jolanda de Boer; Theodore R Levin; Chyke Doubeni; Bruce H Fireman; Charles P Quesenberry
Journal:  Clin Gastroenterol Hepatol       Date:  2012-09-14       Impact factor: 11.382

8.  Colorectal adenoma characteristics as predictors of recurrence.

Authors:  C Bonithon-Kopp; F Piard; C Fenger; E Cabeza; C O'Morain; O Kronborg; J Faivre
Journal:  Dis Colon Rectum       Date:  2004-03       Impact factor: 4.585

9.  Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital.

Authors:  Paul C Schroy; Alison Coe; Clara A Chen; Michael J O'Brien; Timothy C Heeren
Journal:  Ann Intern Med       Date:  2013-07-02       Impact factor: 25.391

10.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

Authors:  Bernard Levin; David A Lieberman; Beth McFarland; Robert A Smith; Durado Brooks; Kimberly S Andrews; Chiranjeev Dash; Francis M Giardiello; Seth Glick; Theodore R Levin; Perry Pickhardt; Douglas K Rex; Alan Thorson; Sidney J Winawer
Journal:  CA Cancer J Clin       Date:  2008-03-05       Impact factor: 508.702

View more
  9 in total

1.  Reducing racial disparity in colorectal cancer burden.

Authors:  Adeyinka O Laiyemo
Journal:  Dig Dis Sci       Date:  2014-09       Impact factor: 3.199

2.  Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study.

Authors:  Thomas F Imperiale; Patrick O Monahan; Timothy E Stump; Elizabeth A Glowinski; David F Ransohoff
Journal:  Ann Intern Med       Date:  2015-09-01       Impact factor: 25.391

3.  Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Samir Gupta; David Lieberman; Joseph C Anderson; Carol A Burke; Jason A Dominitz; Tonya Kaltenbach; Douglas J Robertson; Aasma Shaukat; Sapna Syngal; Douglas K Rex
Journal:  Gastroenterology       Date:  2020-02-07       Impact factor: 22.682

4.  Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Samir Gupta; David Lieberman; Joseph C Anderson; Carol A Burke; Jason A Dominitz; Tonya Kaltenbach; Douglas J Robertson; Aasma Shaukat; Sapna Syngal; Douglas K Rex
Journal:  Gastrointest Endosc       Date:  2020-02-07       Impact factor: 9.427

5.  Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Samir Gupta; David Lieberman; Joseph C Anderson; Carol A Burke; Jason A Dominitz; Tonya Kaltenbach; Douglas J Robertson; Aasma Shaukat; Sapna Syngal; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2020-03       Impact factor: 12.045

6.  A Combination of Fecal Immunochemical Test Results and Iron Deficiency Anemia for Detection of Advanced Colorectal Neoplasia in Asymptomatic Men.

Authors:  Nam Hee Kim; Mi Yeon Lee; Jung Ho Park; Dong Il Park; Chong Il Sohn; Kyuyong Choi; Yoon Suk Jung
Journal:  Yonsei Med J       Date:  2017-09       Impact factor: 2.759

7.  Is Colonoscopic Screening Necessary for Patients Younger than 50 Years with Gastric Adenoma or Cancer?

Authors:  Nam Hee Kim; Jung Ho Park; Dong Il Park; Chong Il Sohn; Yoon Suk Jung
Journal:  J Korean Med Sci       Date:  2017-08       Impact factor: 2.153

8.  Should asymptomatic young men with iron deficiency anemia necessarily undergo endoscopy?

Authors:  Nam Hee Kim; Jung Ho Park; Dong Il Park; Chong Il Sohn; Kyuyong Choi; Yoon Suk Jung
Journal:  Korean J Intern Med       Date:  2018-01-05       Impact factor: 2.884

Review 9.  Black and White Differences in Colorectal Cancer Screening and Screening Outcomes: A Narrative Review.

Authors:  Carolyn M Rutter; Amy B Knudsen; Jennifer S Lin; Kathryn E Bouskill
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-11-03       Impact factor: 4.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.